Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Categories
  3. Pharmacology

Pharmacology Research

Browse the latest research summaries in the field of pharmacology for spinal cord injury patients and caregivers.

Showing 611-620 of 639 results

PharmacologyRegenerative MedicineNeurology

Neuroprotection and immunomodulation by dimethyl fumarate and a heterologous fibrin biopolymer after ventral root avulsion and reimplantation

J Venom Anim Toxins incl Trop Dis, 2020 • May 20, 2020

The study investigates the neuroprotective and immunomodulatory effects of dimethyl fumarate (DMF) combined with a heterologous fibrin sealant (FS) following ventral root avulsion (VRA) and reimplanta...

KEY FINDING: DMF treatment at 15 mg/kg preserved motoneurons and synapses and decreased astrogliosis and microglial reactions, downregulating pro-inflammatory gene transcripts.

Read Summary
PharmacologyNeurology

Botulinum Toxin and Neuronal Regeneration after Traumatic Injury of Central and Peripheral Nervous System

Toxins, 2020 • July 2, 2020

This review summarizes recent experimental findings on the potential efficacy of BoNTs in favoring nerve regeneration after traumatic injury in the peripheral nervous system, such as the injury of per...

KEY FINDING: BoNT/A has shown potential in promoting axonal regeneration after peripheral nerve injury (PNI), which was observed from experimental and clinical data.

Read Summary
PharmacologyNeurology

Neurotropic activity and safety of methylene-cycloalkylacetate (MCA) derivative 3‑(3-allyl-2-methylenecyclohexyl) propanoic acid

ACS Chem. Neurosci., 2020 • July 15, 2020

This study investigates the neurotropic activity and safety of a methylene-cycloalkylacetate (MCA) derivative, HU-MCA-13, as a potential drug for treating polyneuropathies. The research evaluates the ...

KEY FINDING: HU-MCA-13 induced neurite outgrowth in PC12 dopaminergic cell cultures, dorsal root ganglion (DRG) sensory neurons and adult rat spinal cord primary cultures.

Read Summary
Spinal Cord InjuryPharmacologyNeurology

Systemic treatment with a novel basic fibroblast growth factor mimic small-molecule compound boosts functional recovery after spinal cord injury

PLoS ONE, 2020 • July 17, 2020

The study introduces SUN13837, a novel small-molecule compound that mimics the beneficial effects of bFGF without its proliferative side effects. In vitro experiments demonstrated that SUN13837 promot...

KEY FINDING: SUN13837 promotes neurite outgrowth in primary cultures of rat hippocampal neurons, similar to bFGF.

Read Summary
Spinal Cord InjuryPharmacologyNeurology

Revealing the Therapeutic Potential of Botulinum Neurotoxin Type A in Counteracting Paralysis and Neuropathic Pain in Spinally Injured Mice

Toxins, 2020 • July 31, 2020

The study investigates the therapeutic potential of Botulinum neurotoxin type A (BoNT/A) in treating spinal cord injury (SCI) in mice. BoNT/A is known for its ability to block SNARE complex formation ...

KEY FINDING: BoNT/A induces a complete recovery of muscle and motor function in a murine model of severe spinal cord injury (SCI) when administered spinally within one hour from spinal trauma.

Read Summary
Spinal Cord InjuryPharmacologyNeurology

Spinal cord injury can be relieved by the polysaccharides of Tricholoma matsutake by promoting axon regeneration and reducing neuroinflammation

NeuroReport, 2020 • January 1, 2020

This study investigates the protective effects of Tricholoma matsutake polysaccharides (TMP) on spinal cord injuries (SCIs) both in vitro and in vivo. The results showed that TMP promotes neuronal pro...

KEY FINDING: TMP promoted neurite growth and inhibited the production of TNFα, IL-6, and NF-kappa B in cells treated with hydrogen peroxide.

Read Summary
Spinal Cord InjuryPharmacologyBiomedical

Hydrogel-based local drug delivery strategies for spinal cord repair

Neural Regeneration Research, 2021 • February 1, 2021

Hydrogel-based drug delivery strategies offer unique opportunities to locally deliver drugs to the injured spinal cord with sufficient dose and duration, while avoiding deleterious side effects associ...

KEY FINDING: Hydrogel pore size can be varied to control drug release, with larger pore sizes leading to faster drug release.

Read Summary
Spinal Cord InjuryPharmacologyBiomedical

Novel Approach for Efficient Recovery for Spinal Cord Injury Repair via Biofabricated Nano-Cerium Oxide Loaded PCL With Resveratrol to Improve in Vitro Biocompatibility and Autorecovery Abilities

Dose-Response: An International Journal, 2020 • July 1, 2020

The study successfully developed a biofabricated nano-cerium oxide loaded PCL polymer with RVL, characterizing the nanomaterial through various analytical techniques. The CeO2-PCL/RVL bionanomaterials...

KEY FINDING: Nano CeO2 particles assembled onto PCL/RVL were successfully synthesized using a biocompatible ionic liquid.

Read Summary
PharmacologyMental HealthNeurology

Solid lipid nanoparticles loading with curcumin and dexanabinol to treat major depressive disorder

Neural Regeneration Research, 2021 • March 1, 2021

This study investigates the antidepressant effects of solid lipid nanoparticles loaded with curcumin and dexanabinol in a mouse model of major depressive disorder. The results demonstrate that the nan...

KEY FINDING: Solid lipid nanoparticles loaded with curcumin and dexanabinol increased the mRNA and protein expression levels of mature neuronal markers (NeuN, MAP2, Tuj1) in wild-type mice.

Read Summary
Spinal Cord InjuryPharmacologyNeurology

Association of timing of gabapentinoid use with motor recovery after spinal cord injury

Neurology, 2020 • December 15, 2020

This observational study examined the association between the timing of gabapentinoid administration and motor recovery after spinal cord injury. The study found that early administration of gabapenti...

KEY FINDING: Early administration (within 30 days) of gabapentinoids after spinal cord injury is associated with improved motor recovery.

Read Summary
Previous
1...61626364
Next